APOB and peripheral arterial disease: When additionally adjusting for apolipoprotein B, estimates were similar for risk of ischaemic stroke and any ASCVD, attenuated for risk of peripheral artery disease, and strengthened for risk of myocardial infarction (ESM Fig. 6).